Showing results (1-10 of 7) with videos related to
Sort By:
Pageof 1
Cell Cycle (Georgetown, Tex.)|October 22, 2009
Insights into the function of the human P-TEFb component CDK9 in the regulation of chromatin modifications and co-transcriptional mRNA processingJudith Pirngruber, Andrei Shchebet, Steven A JohnsenInvestigative Ophthalmology & Visual Science|June 18, 2010
PKC{alpha} is essential for the proper activation and termination of rod bipolar cell responseKlaus Ruether, Andreas Feigenspan, Judith Pirngruber, et al.Current Oncology (Toronto, Ont.)|October 27, 2023
The Combined Therapy of Cabozantinib, Crizotinib, and Osimertinib in a Lung Cancer Patient with Acquired MET Amplification and Resistance MutationsBalázs Jóri, Christine Vössing, Judith Pirngruber, et al.EMBO Reports|July 4, 2009
CDK9 directs H2B monoubiquitination and controls replication-dependent histone mRNA 3'-end processingJudith Pirngruber, Andrei Shchebet, Lisa Schreiber, et al.Cancer Research|January 22, 2009
Antitumor effects of a combined 5-aza-2'deoxycytidine and valproic acid treatment on rhabdomyosarcoma and medulloblastoma in Ptch mutant miceInes Ecke, Frauke Petry, Albert Rosenberger, et al.Genes & Development|October 4, 2008
The histone H2B-specific ubiquitin ligase RNF20/hBRE1 acts as a putative tumor suppressor through selective regulation of gene expressionEfrat Shema, Itay Tirosh, Yael Aylon, et al.Cancers|July 14, 2023
Development of the NOGGO GIS v1 Assay, a Comprehensive Hybrid-Capture-Based NGS Assay for Therapeutic Stratification of Homologous Repair Deficiency Driven Tumors and Clinical ValidationEva-Maria Willing, Claudia Vollbrecht, Christine Vössing, et al.Pageof 1